The Investment Doctor

This article was written by Follow The Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon. He strongly believes a portfolio should consist of a mixture of dividend and growth stocks. He is the […]

This article was written by Follow The Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon. He strongly believes a portfolio should consist of a mixture of dividend and growth stocks. He is the

Carlyle Secured Lending: Baby Bonds Offer 5.9% YTC For 15 Months Source link The Investment Doctor

JHVEPhoto Introduction One of the interesting elements of preferred shares in Canada is that some of the issues (and then predominantly preferred equity issued by larger companies) have a conversion component. Within the preferred security spectrum, you generally have two

ridham supriyanto/iStock Editorial via Getty Images Introduction I don’t think JPMorgan (NYSE:JPM) needs to be introduced to any investor. As a US-based financial conglomerate, the financial institution is a household name. While I also like the company from an earnings

Ceri Breeze/iStock Editorial via Getty Images Introduction In December of last year, I argued Bank of America’s (NYSE:BAC) non-callable preferred shares were a good idea to speculate on a rate cut (and on decreasing interest rates on the financial markets).